510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2339-2017Class II

VIDAS Testosterone, Ref 30418

bioMerieux, Inc. / initiated 2017-05-15 / Terminated

bioMerieux, Inc. began a recall of VIDAS Testosterone, Ref 30418 on . FDA classified it as Class II and gives the reason as "Complaints were received from customers observing falsely overestimate results or external quality control higher results than expected when performing tests with VIDAS Testosterone". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2339-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
bioMerieux, Inc.
Product
VIDAS Testosterone, Ref 30418
Product code
CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone
Reason for recall
Complaints were received from customers observing falsely overestimate results or external quality control higher results than expected when performing tests with VIDAS Testosterone.
FDA root cause
Under Investigation by firm
Action
An Urgent Product Safety Notice was sent on 5/15/2017 to consignees. The Notice requested that they discontinue use and discard any remaining inventory of the product, and to identify any possible falsely over estimated results and determine appropriate actions if relevant. The Notice also included a response form to be returned to Biomerieux.
Quantity in commerce
742
Distribution
AR, CA, CO, GA, IL, IA, MI, MN, MT, NY, OK, TN, TX, WY, Columbia, Costa Rica, El Salvador, France, Hong Kong, Jordan, Nicaragua, Russian Fed., Sri Lanka, Sweden, Ukraine
Product codes and lots
Lots 1004878310 & 1005001080

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2339-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2339-2017Class IITerminatedVoluntary: Firm initiated